Colin A Walsh, Kate H Moore. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Anticholesteremic Agents/adverse effectsBotulinum Toxins, Type A/administration & dosageDrug ResistanceFemaleHumansMaleNeuromuscular Agents/administration & dosagePatient SelectionUrinary Bladder, Overactive/drug therapy
Substances: See more » Anticholesteremic AgentsNeuromuscular AgentsBotulinum Toxins, Type A
Year: 2012 PMID: 22488771 DOI: 10.1002/nau.21237
Source DB: PubMed Journal: Neurourol Urodyn ISSN: 0733-2467 Impact factor: 2.696